On Mounjaro? This Measurement Matters More Than Pounds Lost скачать в хорошем качестве

On Mounjaro? This Measurement Matters More Than Pounds Lost

Waist circumference and visceral fat may predict heart disease, type 2 diabetes, and metabolic syndrome better than body weight alone—especially if you’re on Mounjaro or another GLP-1 medication. In this video, I break down why a 40-inch waist is a critical health threshold for men over 50, how abdominal obesity increases cardiovascular risk, and what actually happens metabolically as you reduce central fat. We’ll look at insulin resistance, fatty liver disease, high blood pressure, sleep apnea, and long-term mortality risk—and why the scale can mislead you. If you’re using Mounjaro (tirzepatide), semaglutide, or another GLP-1 receptor agonist, this is the measurement you should be tracking alongside weight loss. The goal isn’t just pounds lost—it’s visceral fat reduction and metabolic risk compression. My SKOOL Community - GLP-1 Uncensored Support Group: https://www.skool.com/glp-1-uncensore... Subscribe for weekly GLP-1 updates, over-50 health optimization strategies, and real data from my own journey.